Neogen (NEOG) Competitors $5.50 +0.26 (+4.96%) Closing price 04:00 PM EasternExtended Trading$5.50 0.00 (-0.09%) As of 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors Haemonetics ICU Medical DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Neogen (NASDAQ:NEOG) and Haemonetics (NYSE:HAE) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership. Do analysts recommend NEOG or HAE? Neogen currently has a consensus price target of $7.50, suggesting a potential upside of 36.36%. Haemonetics has a consensus price target of $97.30, suggesting a potential upside of 25.08%. Given Neogen's higher probable upside, analysts plainly believe Neogen is more favorable than Haemonetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Haemonetics 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more risk & volatility, NEOG or HAE? Neogen has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Is NEOG or HAE more profitable? Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-53.56% 2.69% 1.82% Haemonetics 12.32%26.37%9.22% Which has preferable earnings and valuation, NEOG or HAE? Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$924.22M1.29-$9.42M-$2.23-2.47Haemonetics$1.36B2.75$167.68M$3.3123.50 Do insiders & institutionals hold more shares of NEOG or HAE? 96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 1.1% of Neogen shares are owned by insiders. Comparatively, 1.8% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer NEOG or HAE? In the previous week, Neogen had 1 more articles in the media than Haemonetics. MarketBeat recorded 8 mentions for Neogen and 7 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.27 beat Neogen's score of 0.06 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Haemonetics 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHaemonetics beats Neogen on 14 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.14B$10.50B$5.50B$8.96BDividend YieldN/A2.08%5.25%4.02%P/E Ratio-2.4711.1119.9019.84Price / Sales1.2931.31436.90127.27Price / Cash5.1122.7937.0657.97Price / Book0.383.728.125.62Net Income-$9.42M$235.43M$3.16B$248.50M7 Day Performance5.16%3.19%4.40%5.54%1 Month Performance-0.36%2.98%4.09%7.52%1 Year Performance-62.66%-10.27%34.53%22.06% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen4.0707 of 5 stars$5.50+5.0%$7.50+36.4%-65.3%$1.14B$924.22M-2.472,110HAEHaemonetics4.875 of 5 stars$74.77+1.3%$96.80+29.5%-11.1%$3.59B$1.36B22.593,023News CoverageAnalyst UpgradeICUIICU Medical4.581 of 5 stars$132.15+0.3%$192.67+45.8%+8.7%$3.25B$2.38B-34.5015,000Positive NewsXRAYDENTSPLY SIRONA4.4381 of 5 stars$15.88-0.3%$20.36+28.2%-33.0%$3.16B$3.79B-3.5014,000Positive NewsQDELQuidelOrtho4.4338 of 5 stars$28.82-0.2%$44.33+53.8%+1.5%$1.95B$2.78B-5.806,600STAASTAAR Surgical4.1134 of 5 stars$16.78-0.8%$24.63+46.8%-60.8%$831.11M$313.90M-11.651,211CERSCerus3.1907 of 5 stars$1.41-0.7%$3.50+148.2%-25.5%$269.54M$180.27M-14.10290Positive NewsOSUROraSure Technologies1.8049 of 5 stars$3.00-0.3%$3.00-25.7%$224.40M$185.83M-7.14840News CoverageUTMDUtah Medical Products1.8351 of 5 stars$56.92-1.5%N/A-13.2%$184.99M$40.90M15.06180News CoveragePositive NewsANIKAnika Therapeutics3.7406 of 5 stars$10.58-1.5%$20.00+89.0%-57.4%$151.72M$119.91M-2.73300Positive NewsWSTWest Pharmaceutical Services4.7453 of 5 stars$218.800.0%$320.00+46.3%-31.0%$15.72B$2.89B34.3510,600 Related Companies and Tools Related Companies HAE Competitors ICUI Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEOG Stock Alerts